Pharmaceuticals

Global Immunoglobulins Market Size Projected to Reach $30.89 Billion During the Forecast Period

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Immunoglobulins Market Expected To Expand Between 2025 And 2029?

The immunoglobulins market size has experienced significant expansion in recent years. It is anticipated to increase from $18.85 billion in 2024 to $20.32 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.8%. This historical growth can be attributed to several factors, including the rising prevalence of immunodeficiency disorders, an expanding geriatric population, the increasing adoption of immunoglobulins within hospitals, favorable government reimbursement plans, and the growing incidence of chronic and autoimmune diseases.

The immunoglobulins market size is anticipated to experience rapid expansion in the coming years, projected to reach $30.89 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.0%. This growth during the forecast period is attributable to increasing investment in developing advanced technologies, growing awareness regarding immunodeficiency therapies, a rising preference for these therapies among physicians, an expanding number of emerging markets, and the broadening of applications in sports and fitness. Major trends expected in this period encompass the development of wearable and smart compression devices, the customization of compression therapy solutions, the integration of compression therapy into wound care management, an increased emphasis on patient comfort and compliance in compression therapy, and collaborations between manufacturers and healthcare providers to enhance patient outcomes.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

Which Drivers Are Impacting The Immunoglobulins Market?

The rising number of elderly individuals fuels the expansion of the immunoglobulins market. Older adults face a significant susceptibility to infectious and autoimmune conditions. An immunoglobulin test assesses the body’s capacity to generate antibodies, which defend against bacteria, viruses, and allergic reactions. For example, a report released by the World Health Organization (WHO), the Switzerland-based international public health agency, indicated in October 2022 that globally, one in six individuals is projected to be 60 or older by 2030. Furthermore, by 2050, the global population aged 60 years or older is anticipated to reach 2.1 billion. Consequently, the growing elderly demographic is projected to boost the demand within the immunoglobulins market throughout the forecast period.

What Are The Major Segments Identified In The Immunoglobulins Market?

The immunoglobulins market covered in this report is segmented –

1) By Product: IGG, IGA, IGM, IGE, IGD.

2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

Subsegments:

1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)

2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA

3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM

4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE

5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD

What Are The Latest Industry Trends Transforming The Immunoglobulins Market?

Companies operating in the immunoglobulins market are actively developing innovative solutions like intravenous immunoglobulins to cater to broader customer bases, drive increased sales, and boost revenue. For instance, in September 2024, the South Korean biotechnology company GC Biopharma introduced ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid into the U.S. market. This product is intended for the treatment of primary humoral immunodeficiency (PI) in adults aged 17 years and older and is now available to patients through specialty pharmacies. This introduction is notable because the U.S. represents the globe’s largest immunoglobulin market, valued at approximately $11.6 billion. GC Biopharma’s objective is to achieve $50 million in ALYGLO sales during its first year, with plans to elevate this figure to $300 million by 2028. This ambitious growth strategy encompasses partnerships with major U.S. pharmacy benefit managers and specialty pharmacies, which are essential for the effective distribution of immunoglobulin products.

Which Key Players Are Driving Competition In The Immunoglobulins Market?

Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Which Region Currently Holds The Largest Share Of The Immunoglobulins Market?

North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Immunoglobulins Market Report:

https://www.thebusinessresearchcompany.com/customise?id=5284&type=smp

Browse Through More Reports Similar to the Global Immunoglobulins Market 2025, By The Business Research Company

Orphan Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795